Newsfeeds - Spark Newswire

1 minute read

NGM Biopharmaceuticals Q4 EPS $(0.45) Beats $(0.51) Estimate, Sales $18.18M Beat $6.76M Estimate

Today, 3:42 AM

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.51) by 11.76 percent. This is a 28.57 percent decrease over losses of $(0.35) per share

NGM

2 minute read

$2.6M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying

By Lisa Levin

Today, 3:42 AM

Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.

EOG

1 minute read

After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm

By Vandana Singh

Today, 3:42 AM

Merck & Co Inc (NYSE:MRK) has notified NGM Biopharmaceuticals Inc (NASDAQ:NGM) that it will not exercise its option to license NGM621 and…

MRK

2 minute read

Reported Late Monday, NGM Bio Gives Presentation Featuring Preclinical Characterization Of NGM936 At 2022 ASH Annual Meeting

By Benzinga Newsdesk

Today, 3:42 AM

--NGM936, a ILT3 x CD3 bispecific T cell engager product candidate, potently induced T cell dependent cytotoxicity (TDCC) against ILT3+ AML cells while inducing minimal cytokine release in preclinical in vivo and in

NGM

3 minute read

NGM Bio Presents Preliminary Data from Phase 1 Monotherapy Dose Escalation Trial of NGM707 in Patients with Advanced or Metastatic Solid Tumors at 2022 ESMO-IO; Said Early Signals of Anti-tumor Activity Demonstrated Across Multiple Tumor Types

By Charles Gross

Today, 3:42 AM

NGM Biopharmaceuticals, Inc.

NGM

1 minute read

Raymond James Maintains Outperform on NGM Biopharmaceuticals, Raises Price Target to $6

By Benzinga Newsdesk

Today, 3:42 AM

Raymond James analyst Steven Seedhouse maintains NGM Biopharmaceuticals (NASDAQ:NGM) with a Outperform and raises the price target from $4 to $6.

NGM

1 minute read

NGM Biopharmaceuticals Q3 EPS $(0.59) Down From $(0.37) YoY, Sales $7.91M Down From $18.57M YoY

By Benzinga Newsdesk

Today, 3:42 AM

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.59) per share. This is a 59.46 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $7.91 million in

NGM

5 minute read

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday

By Lisa Levin

Today, 3:42 AM

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

AGLE

3 minute read

US Stocks Turn Lower; Dow Tumbles Over 100 Points

By Lisa Levin

Today, 3:42 AM

U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping more than 100 points on Thursday.

CABA

4 minute read

Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 3:42 AM

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.

ACOR